PTPN11 and glioblastoma: The inhibitory tyrosine phosphorylation is reversed by the SHP-2/PTPN11 phosphatase, and pharmacological inhibition of SHP-2 suppresses ERK pathway activation and tumors in mouse glioblastoma models [83].